Biopharma

Plays a crucial role in developing lifesaving plasma-based medicines. Plasma, the liquid portion of blood, is rich in proteins and essential components that hold immense therapeutic value. At Grifols, we harness this vital resource to create treatments for individuals worldwide who suffer from chronic and rare, often life-threatening, diseases. By combining our extensive expertise in plasma science with advanced technology platforms, we accelerate the innovation of both plasma-derived and non-plasma therapies, ensuring patients receive the critical care they need.